TELADOC HEALTH, INC. Diluted Shares Outstanding (Weighted Average)
TELADOC HEALTH, INC. (TDOC) reported Diluted Shares Outstanding (Weighted Average) of 181.03 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-30
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 181.03M shares, a 2.90% increase year-over-year.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 179.12M shares, a 2.85% increase year-over-year.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 177.85M shares, a 2.93% increase year-over-year.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 176.93M shares, a 3.17% increase year-over-year.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 176.22M shares, a 3.32% increase from fiscal 2024.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 170.56M shares, a 3.64% increase from fiscal 2023.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 164.58M shares, a 1.93% increase from fiscal 2022.
- TELADOC HEALTH, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 161.46M shares, a 2.88% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 181.03M shares 10-Q · filed 2026-07-30 | 180.08M shares 10-Q · filed 2026-07-30 | 179.33M shares derived: average of 3 quarters · filed 2026-07-30 | 178.73M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 179.12M shares 10-Q · filed 2026-04-30 | 178.49M shares derived: average of 2 quarters · filed 2026-04-30 | 177.97M shares derived: average of 3 quarters · filed 2026-04-30 | 177.46M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | 177.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 177.39M shares derived: average of 2 quarters · filed 2026-02-26 | 176.90M shares derived: average of 3 quarters · filed 2026-07-30 | 176.22M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 176.93M shares 10-Q · filed 2025-10-30 | 176.43M shares derived: average of 2 quarters · filed 2026-07-30 | 175.68M shares 10-Q · filed 2025-10-30 | 174.95M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | 175.92M shares 10-Q · filed 2026-07-30 | 175.04M shares 10-Q · filed 2026-07-30 | 174.28M shares derived: average of 3 quarters · filed 2026-07-30 | 173.59M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | 174.15M shares 10-Q · filed 2026-04-30 | 173.47M shares derived: average of 2 quarters · filed 2026-04-30 | 172.81M shares derived: average of 3 quarters · filed 2026-04-30 | 172.17M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 172.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 172.14M shares derived: average of 2 quarters · filed 2026-02-26 | 171.50M shares derived: average of 3 quarters · filed 2026-02-26 | 170.56M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 171.50M shares 10-Q · filed 2025-10-30 | 170.86M shares derived: average of 2 quarters · filed 2025-10-30 | 169.82M shares 10-Q · filed 2025-10-30 | 168.88M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 170.23M shares 10-Q · filed 2025-07-30 | 168.98M shares 10-Q · filed 2025-07-30 | 168.01M shares derived: average of 3 quarters · filed 2026-02-26 | 167.29M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 167.73M shares 10-Q · filed 2025-05-01 | 166.90M shares derived: average of 2 quarters · filed 2026-02-26 | 166.31M shares derived: average of 3 quarters · filed 2026-02-26 | 165.77M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 166.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 165.60M shares derived: average of 2 quarters · filed 2026-02-26 | 165.12M shares derived: average of 3 quarters · filed 2026-02-26 | 164.58M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 165.12M shares 10-Q · filed 2024-10-31 | 164.65M shares derived: average of 2 quarters · filed 2024-10-31 | 164.08M shares 10-Q · filed 2024-10-31 | 163.60M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 164.17M shares 10-Q · filed 2024-08-01 | 163.55M shares 10-Q · filed 2024-08-01 | 163.09M shares derived: average of 3 quarters · filed 2025-02-27 | 162.75M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 162.92M shares 10-Q · filed 2024-04-26 | 162.55M shares derived: average of 2 quarters · filed 2025-02-27 | 162.28M shares derived: average of 3 quarters · filed 2025-02-27 | 162.05M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 162.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 161.95M shares derived: average of 2 quarters · filed 2025-02-27 | 161.76M shares derived: average of 3 quarters · filed 2025-02-27 | 161.46M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 161.73M shares 10-Q · filed 2023-10-27 | 161.55M shares derived: average of 2 quarters · filed 2023-10-27 | 161.22M shares 10-Q · filed 2023-10-27 | 160.90M shares derived: average of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | 161.38M shares 10-Q · filed 2023-07-28 | 161.00M shares 10-Q · filed 2023-07-28 | 160.63M shares derived: average of 3 quarters · filed 2024-02-23 | 160.33M shares derived: average of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | 160.53M shares 10-Q · filed 2023-05-02 | 160.25M shares derived: average of 2 quarters · filed 2024-02-23 | 159.98M shares derived: average of 3 quarters · filed 2024-02-23 | 159.00M shares derived: average of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | 159.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | 159.71M shares derived: average of 2 quarters · filed 2024-02-23 | 158.49M shares derived: average of 3 quarters · filed 2024-02-23 | 156.94M shares 10-K · filed 2024-02-23 |
| 2021-09-30 | 159.44M shares 10-Q · filed 2022-11-02 | 157.75M shares derived: average of 2 quarters · filed 2022-11-02 | 155.93M shares 10-Q · filed 2022-11-02 | |
| 2021-06-30 | 156.06M shares 10-Q · filed 2022-08-03 | 154.19M shares 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 152.17M shares 10-Q · filed 2022-05-02 | |||
| 2020-12-31 | 90.51M shares 10-K · filed 2023-03-01 | |||
| 2019-12-31 | 71.84M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |